CYPRESS SEMICONDUCTOR CORP /DE/
10-Q, 2000-08-16
SEMICONDUCTORS & RELATED DEVICES
Previous: SPORTSMANS GUIDE INC, 10-Q, EX-27, 2000-08-16
Next: CYPRESS SEMICONDUCTOR CORP /DE/, 10-Q, EX-27.1, 2000-08-16




SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


|X|  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended July 2, 2000

OR

|_|  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934


Commission file number 1-10079

CYPRESS SEMICONDUCTOR CORPORATION

(Exact name of registrant as specified in its charter)


Delaware
(State or other jurisdiction of
incorporation or organization)
94-2885898
(I.R.S. Employer
Identification No.)


3901 North First Street, San Jose, California 95134-1599
(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (408) 943-2600


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes |X| No |_|

The total number of shares of the registrant’s common stock outstanding as of July 30, 2000, was 120,609,000.





CYPRESS SEMICONDUCTOR CORPORATION


Part I — FINANCIAL INFORMATION    
     Item 1.   Financial Statements 
                          Condensed Consolidated Balance Sheets     
                          Condensed Consolidated Statements of Operations     
                          Condensed Consolidated Statements of Cash Flows     
                          Notes to Condensed Consolidated Financial Statements     
     Item 2.   Management’s Discussion and Analysis of Financial Condition      
     Item 3.   Quantitative and Qualitative Disclosure About Market Risk      
     
Part II— OTHER INFORMATION 
     Item 1.   Legal Proceedings     
     Item 4.   Submission of Matters to a vote of Security Holders     
     Item 6.   Exhibits and Reports on Form 8-K     
     Signatures     



CYPRESS SEMICONDUCTOR CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per-share data)
(Unaudited)


July 2,
2000

January 2,
2000

                                                                           ASSETS      
Current assets: 
  Cash and cash equivalents  $578,669   $159,088  
  Short-term investments  261,709   121,859  

  Total cash, cash equivalents and short-term investments  840,378   280,947  
  Accounts receivable, net of allowances of $3,924 at July 2, 2000 
    and $3,471 at January 2, 2000  163,979   104,143  
  Inventories, net  101,649   98,786  
  Other current assets  85,583   78,117  

          Total current assets  1,191,589   561,993  
  Property, plant and equipment, net  450,706   358,206  
  Long-term investments  197,675   111,324  
  Restricted investments  60,945   61,198  
  Other assets  72,362   54,237  

              Total assets  $1,973,277   $1,146,958  


The accompanying notes form an integral part of these condensed consolidated financial statements.




CYPRESS SEMICONDUCTOR CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per-share data)
(Unaudited)


July 2,
2000

January 2,
2000

                               LIABILITIES AND STOCKHOLDERS’ EQUITY      
Current liabilities: 
  Accounts payable  $113,925   $103,691  
  Accrued liabilities  76,138   56,291  
  Deferred income on sales to distributors  34,250   21,061  
  Income taxes payable  53,199   20,311  

      Total current liabilities  277,512   201,354  
  Convertible subordinated notes  730,500   160,000  
  Deferred income tax  57,932   56,100  
  Other long-term liabilities  9,934   10,884  

      Total liabilities  1,075,878   428,338  

Commitments and Contingencies (Note 14) 
Stockholders’ equity: 
  Preferred stock, $0.01 par value, 5,000 shares authorized; 
    none issued and outstanding     
  Common stock, $0.01 par value, 650,000 and 250,000 shares authorized; 
    124,325 and 119,091 issued; 119,345 and 114,111 outstanding 
    at July 2, 2000 and January 2, 2000  1,243   1,162  
  Additional paid-in capital  616,149   560,771  
  Notes receivable from stockholders  (2,535 ) (8,186 )
  Retained earnings  355,266   237,597  

   970,123   791,344  
Less shares of common stock held in treasury at cost: 
    4,980 shares at July 2, 2000 and January 2, 2000  (72,724 ) (72,724 )

      Total stockholders’ equity  897,399   718,620  

          Total liabilities and stockholders’ equity  $1,973,277   $1,146,958  



The accompanying notes form an integral part of these condensed consolidated financial statements.




CYPRESS SEMICONDUCTOR CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per-share data)
(Unaudited)


Three Months Ended
July 2,
2000

July 4,
1999

Revenues   $300,834   $170,825  

Costs and expenses: 
  Cost of revenues  135,143   95,671  
  Research and development  42,742   34,067  
  Selling, general and administrative  36,513   26,850  
  Acquisition and merger costs  7,592   6,070  
  Restructuring credits  (485 ) (100 )

      Total operating costs and expenses  221,505   162,558  

Operating income  79,329   8,267  
Interest expense  (5,501 ) (2,465 )
Interest income and other  12,315   3,871  

Income before income taxes  86,143   9,673  
Provision for income taxes  20,514   1,210  

Net income  $65,629   $8,463  

Net income per share: 
  Basic  $0.56   $0.08  
  Diluted  $0.49   $0.08  
Shares used in per share calculations: 
  Basic  118,186   107,484  
  Diluted  142,117   112,838  


The accompanying notes form an integral part of these condensed consolidated financial statements.




CYPRESS SEMICONDUCTOR CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per-share data)
(Unaudited)


Six Months Ended
July 2,
2000

July 4,
1999

 
Revenues:  $565,075   $330,118  

Costs and expenses: 
  Cost of revenues  265,969   188,969  
  Research and development  81,135   66,241  
  Selling, general and administrative  70,139   51,801  
  Acquisition and merger costs  11,801   9,712  
  Restructuring credits  (485 ) (3,710 )

      Total operating costs and expenses  428,559   313,013  

Operating income  136,516   17,105  
Interest expense  (10,067 ) (4,790 )
Interest income and other  26,717   7,149  

Income before income taxes  153,166   19,464  
Provision for income taxes  35,497   2,196  

Net income  $117,669   $17,268  

Net income per share: 
  Basic  $1.01   $0.17  
  Diluted  $0.89   $0.16  
Shares used in per share calculations: 
  Basic  117,014   104,097  
  Diluted  140,433   108,718  

The accompanying notes form an integral part of these condensed consolidated financial statements.



CYPRESS SEMICONDUCTOR CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

Six Months Ended
July 2,
2000

July 4,
1999

Cash flow from operating activities:      
  Net income  $117,669   $17,268  
  Adjustments to reconcile net income to net cash 
       provided by operating activities: 
    Depreciation and amortization  64,157   54,811  
    Gain on sale of FCT product line  (5,000 )  
    Acquired in-process research and development  2,025   4,019  
    Other non-recurring costs  1,964    
    Restructuring credits  (485 ) (3,710 )
    Loss on sales of property, plant and equipment  355    
    Amortization of debt issuance costs  1,465   265  
Changes in operating assets and liabilities: 
  Accounts receivable  (59,785 ) (18,090 )
  Inventories  (4,017 ) (15,365 )
  Other assets  (5,950 ) (3,489 )
  Accounts payable and accrued liabilities  32,269   10,737  
  Deferred income  13,189   4,551  
  Income taxes payable  32,888   1,202  

      Net cash flow generated from operating activities  190,744   52,199  

Cash flow from investing activities: 
  Purchase of investments  (275,168 ) (112,689 )
  Sale or maturities of investments  48,967   23,321  
  Notes Receivable    (3 )
  Acquisition of Anchor    (14,956 )
  Acquisition of Arcus    (9,883 )
  Acquisition of property, plant and equipment  (151,768 ) (41,499 )
  Proceeds from sale of FCT product line  7,500    
  Proceeds from the sale of equipment  320   7,679  

      Net cash flow used for investing activities  (370,149 ) (148,030 )

Cash flow from financing activities: 
  Issuance of convertible subordinated notes, net of issuance costs  554,812    
  Issuance of common shares (1)  39,558    
  Re-issuance of treasury shares    57,985  
  Repayment of stockholders’ notes  5,651    
  Issuance of notes to employees    (7,892 )
  Borrowing from (repayment of) notes payable and line of credit  (1,085 ) 499  
  Other long-term liabilities  50   (4,531 )

      Net cash flow generated by financing activities  598,986   46,061  

      Net change in cash during the quarter ended March 31, 1999 for merger    (2,339 )
Net increase in cash and cash equivalents  419,581   (52,109 )
Cash and cash equivalents, beginning of year  159,088   151,390  

Cash and cash equivalents, end of period  $578,669   $99,281  

Supplemental Disclosure of Non-Cash Flow Information 
(1) Common stock issued for acquisition of RadioCom  10,214    

The accompanying notes form an integral part of these condensed consolidated financial statements.




CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For the Quarter Ended July 2, 2000
(Unaudited)

Note 1 — Interim Statements

In the opinion of management of Cypress Semiconductor Corporation (“Cypress”), the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting solely of normal recurring adjustments) necessary to present fairly the financial information included therein. Cypress believes that the disclosures are adequate to make the information not misleading. However, it is suggested that this financial data be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended January 2, 2000 included in Cypress’s 1999 Annual Report on Form 10-K, Cypress’s Current Report on Form 8-K dated March 9, 2000, and Cypress’s Current Report on Form 8-K/A dated June 16, 2000.

Beginning with its 1998 fiscal year-end, Cypress ended its fiscal months, quarters and years on Sundays. For interim financial reporting purposes, Cypress reports on a 13-week quarter. The results of operations for the three-month period ended July 2, 2000 are not necessarily indicative of the results to be expected for the full year.

Note 2 — Acquisition of RadioCom Corporation

On June 29, 2000, Cypress acquired all of the outstanding capital stock of RadioCom Corporation (“RadioCom”). RadioCom specializes in the design and development of semiconductor radio frequency (RF) integrated circuits. The acquisition was accounted for using purchase accounting. Accordingly, the estimated fair value of assets acquired and liabilities assumed were included in Cypress’s condensed consolidated balance sheet as of June 29, 2000, the effective date of the purchase. The results of operations of RadioCom from June 29, 2000 through Cypress’s quarter ended July 2, 2000 were not significant and were therefore excluded from that quarter’s reported results. There are no significant differences between the accounting policies of Cypress and RadioCom.

Cypress acquired RadioCom for a total consideration of $10.2 million in stock, which excludes direct acquisition costs of $0.2 million for legal and accounting fees. The total purchase price was allocated to the estimated fair value of assets acquired and liabilities assumed based on appraisals prepared by management using valuation methods that are widely recognized and commonly used in the valuation of technology assets. The asset values estimates are as follows:


(In thousands)
       Fair value of tangible net assets   $      51
       In-process research and development   2,025  
       Current technology  1,752  
       Assembled workforce  802  
       Excess of purchase price over identifiable net 
          assets acquired  5,584  

      Total  $10,214


The valuation method used to value the in-process technology of RadioCom is a form of discounted cash flow method commonly known as the “percentage of completion” approach whereby the cash flow derived from the technology is multiplied by the percentage of completion of the in-process technology. This approach is a widely recognized appraisal method and is commonly used to value technology assets. The value of the in-process technology of RadioCom is the discounted expected future cash flow attributable to the in-process technology, taking into consideration the percentage of completion of products utilizing this technology, utilization of pre-existing technology, the risks related to the characteristics and applications of the technology, existing and future markets, and the technological risk associated with completing the development of the technology. The cash flow derived from the in-process technology projects was discounted using a discount rate of 20.0%, which Cypress believes was appropriate for the risk of this technology for which commercial feasibility had not been established. The percentage of completion for each in-process project was determined by identifying milestones of completed project steps as compared to the remaining milestones to be completed to bring the project to technical and commercial feasibility. Milestones were based on management’s estimate of tasks completed, value added and degree of difficulty of the portion of the project completed as of the acquisition date, in comparison with the tasks to be completed to bring the project to technical and commercial feasibility.




The value of current technology was determined by estimating the future cash flows to be derived from products based on existing commercially feasible technologies at the date of the acquisition, and discounting associated cash flow using a discount rate of 35.0%, which Cypress believes was appropriate for the business risks inherent in manufacturing and marketing these products. Factors considered in estimating the future cash flow to be derived from the existing technology include risks related to the characteristics and applications of the technology, existing and future markets, and assessment of the age of the technology within its life span.

The value of the assembled workforce is based on estimated costs to replace the existing staff, including recruiting, hiring and training costs for all employee categories to fully deploy a work force of similar size and skill to the same level of productivity as the existing work force.

Development of in-process technology remains a substantial risk to Cypress due to factors including the remaining effort to achieve technical feasibility, rapidly changing customer requirements and competitive threats from other companies and technologies. Additionally, the value of other intangible assets acquired may become impaired. The in-process research and development valuation as well as the valuation of other intangible assets was prepared by management, based on inputs from Cypress and RadioCom management, utilizing valuation methods that are recognized by the SEC staff. However, there can be no assurance that the SEC staff will not take issue with assumptions used in appraiser’s valuation model and require Cypress to revise the amount allocated to in-process research and development.

The amounts allocated to current technology, assembled workforce and residual goodwill are being amortized over their respective estimated useful lives of between six and ten years using the straight-line method.

Note 3 — Merger with Alation Systems, Incorporated

On May 24, 2000, Cypress completed a merger with Alation Systems, Inc. (“Alation”), which was accounted for as a pooling of interests. These condensed consolidated financial statements and the notes to the condensed consolidated financial statements give effect to the merger for all periods presented. The fiscal years of Cypress and Alation were different, and Alation has changed its fiscal periods to coincide with that of Cypress. Cypress’s consolidated balance sheets as of July 2, 2000 and January 2, 2000 have been combined with Alation’s consolidated balance sheets as of July 2, 2000 and December 31, 1999 respectively. For the purpose of the condensed consolidated statements of operations for the periods ended July 2, 2000 and July 4, 1999, Cypress’s statements of operations have been combined with Alation’s statements of operations for the three month and six month periods ended July 2, 2000 and June 30, 1999 respectively.

The results of operations previously reported by the separate companies prior to the merger and included in the results of operations for the three month periods ended April 2, 2000 and April 4, 1999 and the six months ended July 4, 1999 are presented below.

Three months ended April 2, 2000:


Cypress
Alation
Total
(In thousands)
          Total revenue   $264,241   $        —   $264,241  
           Net income  $  53,120   $  (1,080 ) $  52,040  

Three months ended April 4, 1999:

Cypress
Alation
Total
(In thousands)
          Total revenue   $159,124   $       169   $159,293  
          Net income  $    9,275   $      (470 ) $    8,805  

Six months ended July 4, 1999:

Cypress
Alation
Total
(In thousands)
          Total revenue   $329,920   $       198   $300,118  
          Net income  $  18,546   $   (1,278 ) $  17,268  



During the quarter ended July 2, 2000, Cypress recorded merger-related costs of $1.4 million related to the acquisition of Alation. These charges, which consist primarily of deferred compensation charges, legal, and accounting, have been included under acquisition and merger costs in the condensed consolidated statements of operations.

Note 4 — Merger with Galvantech Incorporated

On March 2, 2000, Cypress completed a merger with Galvantech, Inc. and its subsidiaries (“Galvantech”), which was accounted for as a pooling of interests. These condensed consolidated financial statements and the notes to the condensed consolidated financial statements give effect to the merger for all periods presented. The fiscal years of Cypress and Galvantech were different, and Galvantech has changed its fiscal periods to coincide with that of Cypress. Cypress’s consolidated balance sheets as of April 2, 2000 and January 2, 2000 have been combined with Galvantech’s consolidated balance sheets as of April 2, 2000 and December 31, 1999 respectively. For the purpose of the condensed consolidated statements of operations for the periods ended April 2, 2000 and April 4, 1999, Cypress’s statements of operations have been combined with Galvantech’s statements of operations for the three month periods ended April 2, 2000 and March 31, 1999, respectively. As a result of combining Cypress’s and Galvantech’s financial statements for the fiscal years ended January 2, 2000 and January 3, 1999, the results of operations of Galvantech for the quarter ended March 31, 1999 were included in the supplementary consolidated statements of operations of both 1998 and 1999. Therefore, the balance sheet and cash and cash equivalents for the quarter ended December 31, 1998 and March 31, 1999 are the same.

The results of operations previously reported by the separate companies prior to the merger and included in the results of operations for the three month period ended April 4, 1999 are presented below.

Three months ended April 4, 1999:


Cypress
Galvantech
Total
  (in thousands)  
Total revenue   $151,591   $    7,533   $159,124  
Net income  $    8,684   $       591   $    9,275  

During the quarter ended April 2, 2000, Cypress recorded merger-related costs of $1.8 million related to the acquisition of Galvantech. These charges, which consist primarily of legal, accounting and investment banking fees, have been included under acquisition and merger costs in the condensed consolidated statements of operations.

Note 5 — Sale of FCT Business

On February 25, 2000, Cypress sold its FCT business including inventories, product software, all technical data, and a license for the related intellectual property. Total proceeds from the sale were $7.5 million and Cypress recorded a gain of $5.0 million from the sale. In conjunction with this sale, we entered into a supply agreement for the related inventories. Inventories of $1.2 million were supplied under the agreement in Q1 2000. We expect to complete our obligations under the supply agreement during the fourth quarter of our fiscal year 2000. Revenues from FCT products were approximately 1% of our 1999 revenues.

Note 6 — Acquisition of Arcus Technology Companies

On June 30, 1999, Cypress acquired all of the outstanding capital stock of Arcus Technology (USA), Inc. and the assets of Arcus Technology (India) Limited (referred to as “Arcus” on a combined basis). Arcus specializes in new data communications arenas including dense wave multiplexing (which allows multiple signals to be transmitted over a single fiber optic cable) and “IP over SONET” (the technology needed to code and decode internet traffic to send it over the telephone system). The acquisition was accounted for using purchase accounting. Accordingly, the estimated fair value of assets acquired and liabilities assumed were included in Cypress’s condensed consolidated balance sheet as of June 30, 1999, the effective date of the purchase. The results of operations of Arcus from June 30, 1999 through Cypress’s quarter ended July 4, 1999 were not significant and were therefore excluded from that quarter’s reported results. There are no significant differences between the accounting policies of Cypress and Arcus.




Cypress acquired Arcus for a total consideration of $17.7 million, including cash of $11.5 million and stock of $6.2 million, excluding direct acquisition costs of $0.8 million for legal and accounting fees. Through July 2, 2000, Cypress paid $9.9 million in cash and issued $6.2 million in stock. Cypress incurred a non-recurring charge of $2.0 million in the quarter ended July 2, 2000 due to an acceleration of contractual obligations. The remaining $1.6 million in cash will be paid as certain performance milestones are reached. The total purchase price was allocated to the estimated fair value of assets acquired and liabilities assumed based on independent appraisals and management estimates as follows:


(In thousands)
       Fair value of tangible net assets   $     391
       In-process research and development   2,500  
       Current technology  4,400  
       Assembled workforce  1,600  
       Deferred compensation  5,553  
       Excess of purchase price over identifiable net 
          assets acquired  3,264  

      Total  $17,708


Note 7— Acquisition of Anchor Chips, Inc.

On May 25, 1999, Cypress acquired all of the outstanding capital stock of Anchor Chips, Inc. (“Anchor”), a company that designs and markets microcontroller chips to support the Universal Serial Bus applications. The acquisition was accounted for using purchase accounting. Accordingly, the estimated fair value of assets acquired and liabilities assumed were included in Cypress’s condensed consolidated balance sheet as of and since May 25, 1999, the effective date of the purchase. The results of operations of Anchor were included in Cypress’s consolidated results of operations as of and since the effective date of the purchase.

Cypress paid approximately $15.0 million in cash, which excludes direct acquisition costs of $0.7 million for investment banking, legal and accounting fees. In addition Cypress assumed net liabilities of approximately $0.9 million. The total purchase consideration of $15.0 million was allocated to the estimated fair value of assets acquired and liabilities assumed based on the valuation completed by management, using a valuation methodology commonly applied by independent appraisers, as follows:


(In thousands)
       Fair value of tangible net assets   $    (919 )
       In-process research and development   1,519  
       Assembled workforce  1,320  
       Current technology  13,036  

      Total  $ 14,956


Note 8 — Merger with IC WORKS Incorporated

On April 1, 1999, Cypress completed a merger with IC WORKS Incorporated (“ICW”), which was accounted for as a pooling of interests. The condensed consolidated financial statements and the notes to the condensed consolidated financial statements give effect to the merger for all periods presented. The fiscal years of Cypress and ICW were different. ICW has changed its fiscal year-end to coincide with that of Cypress. Cypress’s consolidated statements of operations for the period ended April 4, 1999 have been combined with ICW’s consolidated statements of operations for the corresponding three month period ended April 3, 1999.




During the quarter ended April 4, 1999, Cypress recorded merger-related transaction costs of $3.7 million related to the acquisition of ICW. These charges, which consist primarily of investment banking and other professional fees, have been included under acquisition and merger costs in the condensed consolidated statements of operations.

Note 9 — Cash and Investments


July 2,
2000

January 2,
2000

(In thousands)
    Cash and cash equivalents   $578,669   $159,088  
  Short-term investments  261,709   121,859  
  Long-term investments  197,675   111,324  
  Restricted investments  60,945   61,198  

  Total  $1,098,998   $453,469  


Note 10 —Inventories


July 2,
2000

January 2,
2000

(In thousands)
  Raw materials   $  10,479   $13,360  
  Work-in-process  56,331   49,328  
  Finished goods  34,839   36,098  

  Total  $101,649   $98,786  



Note 11 — Earnings Per Share

Statement of Accounting Standards No. 128 (“SFAS 128”) requires a reconciliation of the numerators and denominators of the basic and diluted per share computations. Basic earnings per share (“EPS”) is computed by dividing net income available to stockholders (numerator) by the weighted average number of common shares outstanding (denominator) during the period. Diluted EPS is computed using the weighted average number of common and all potentially dilutive common shares outstanding during the period. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options and the if-converted method is used for determining the number of shares assumed issued from the conversion of the convertible subordinated notes. Following is a reconciliation of the numerators and denominators of the basic and diluted EPS computations for the periods presented below. Three months ended July 2, 2000 and July 4, 1999:


July 2, 2000
July 4, 1999
Income
Shares
Per-Share
Amount

Income
Shares
Per-Share
Amount

(In thousands, except per share amounts)
Basic EPS:              
  Net income  $65,629   118,186   $0.56   $8,463   107,484   $0.08  
Effects of dilutive 
securities: 
  6% Convertible Notes  1,464   6,772    
  4% Convertible Notes  1,726   6,119    
  3.75% Convertible Notes  128   358    
  7.00% Convertible Notes  2   15     74
  Stock options    10,667     5,280

Diluted EPS: 
  Net income  $68,949   142,117   $0.49   $8,463   112,838   $0.08  




Six months ended July 2, 2000 and July 4, 1999:


July 2, 2000
July 4, 1999
Income
Shares
Per-Share
Amount

Income
Shares
Per-Share
Amount

(In thousands, except per share amounts)
Basic EPS:              
  Net income  $117,66 9 117,014   $1.01   $17,268   104,097   $0.17  
Effects of dilutive securi  s:  
  6% Convertible Notes  3,336   6,772  
  4% Convertible Notes  3,375   5,380  
  3.75% Convertible Notes  128   179  
  7.00% Convertible Notes  5   31   48
  Stock options    11,057   4,573

Diluted EPS: 
  Net income  $124,51 3 140,433   $0.89   $17,268   108,718   $0.16  


At July 2, 2000 and July 4, 1999, stock options outstanding were 23,128,000 and 23,359,000, respectively. Of the options outstanding, 471,000 and 4,735,000 shares, on a weighted average basis, were excluded from the computation of diluted EPS because their exercise prices were greater than the average market price of common shares during the respective quarters. Convertible debentures outstanding at July 4, 1999 which were convertible to 6,772,000 shares of common stock were also excluded from diluted EPS in that period as their effect was anti-dilutive.

Note 12 — Restructuring

   1998 Restructuring

In March 1998, Cypress implemented an overall cost reduction plan and recorded a $57.1 million restructuring charge related to the impairment of assets ($46.4 million), reduction in work force ($4.8 million), and other transaction costs ($5.9 million). The restructuring entailed:


The shutdown of Fab 3, located in Bloomington, Minnesota and consolidation of parts of Fab 3 operations with other operations of Cypress.
The discontinuance of the 0.6-micron 256K Static Random Access Memory (“SRAM”) production in Fab 2 located in Texas.
The conversion of an existing research and development fab located in San Jose (“Fab 1”) to eight-inch capability in order to be compatible with the state of the art eight-inch Minnesota manufacturing facility.
The transfer of Cypress’s test operations from its subcontractor, Alphatec, in Thailand to Cypress’s production facility in the Philippines.

The restructuring activities described above included the termination of approximately 850 employees, primarily from manufacturing, both at Cypress and at Alphatec.

During Q2 1998, in conjunction with the closure of Fab 3, Cypress established a reserve for $1.4 million to cover severance costs associated with the reduction of work force at that location. This was based on the anticipated level of payments that would be made to personnel included in the work force reduction. As a part of a review of inventory, it was noted that Cypress required an additional reserve of $0.5 million to cover inventory that was written off. This related to a change in estimate regarding inventory that had been previously reserved.

The following tables set forth charges taken against the restructuring reserve during the six-months ended July 2, 2000 and Cypress’s 1998 restructuring expense and charges taken against the reserve from the date the restructuring commenced through July 2, 2000, respectively.


Balance
January 2,
2000

Utilized
Credits
Balance
July 2,
2000

(In thousands)
Other fixed asset related charges(1)   $1,807   $(159 ) $ —   $1,648  



1998
Restructuring
Expense

Utilized
Credits
Balance
July 2,
2000

(In thousands)
Write-down of inventory (1)   $3,250   $(3,250 ) $ —   $ —  
Severance and other employee related charges(1) (2)  5,334   (2,234 ) (3,100 ) $ —  
Other fixed asset related charges(1)  3,030   (862 ) (520 ) 1,648  
Provision for phase-down and consolidation of 
  manufacturing facilities(1)  976   (637 ) (339 )  

          Total  $12,590   $(6,983 ) $(3,959 ) $1,648  


(1) Classified on the Condensed Consolidated Balance Sheet as part of accrued liabilities.
(2) The amount utilized represents cash payments related to severance of approximately 850 employees.

During the quarter ended April 4, 1999, Cypress reversed $3.7 million of previously provided restructuring costs, $2.2 million of severance and other employee related charges and $0.3 million for the provision for phase-down and consolidation of manufacturing facilities were reversed in conjunction with the completion of the Alphatec restructuring activities. $0.5 million was reversed for other fixed asset related charges based on the determination that a portion of the fixed asset removal costs accrual would not be required. These reversals related to Cypress’s 1998 restructuring activities. Cypress also reversed a $0.7 million reserve for fixed asset installation costs related to its 1996 restructuring activities which was no longer required.

Restructuring activities associated with Fabs 2 and 3 were completed in May and July 1998, respectively, consistent with Cypress’s restructuring schedule except for the disposal of equipment. $0.9 million of severance and other employee related charges were reversed at that time. Fab 1 restructuring was not completed in January 1999 as originally planned. Cypress is in the process of converting its R&D wafer facility in San Jose to eight-inch capability and expects to have the conversion completed by December 2000. The Alphatec consolidation and transfer activity was completed in January 1999, one month later than originally planned.

1997 Restructuring Costs

During the fourth quarter of 1997, Cypress (ICW) made a decision to shut down its wafer fab located in San Jose. In connection with the shut down of the wafer fab, Cypress (ICW) recorded a restructuring charge of $9.9 million related to the impairment of assets ($3.9 million), non-cancelable operating lease commitments ($3.6 million), costs associated with a reduction in work force ($0.2 million) and other transaction costs ($2.2 million). The other transaction costs related primarily to inventory write-offs, expenses incurred to remove and return leased equipment and brokerage and professional fees.

The following tables set forth charges taken against the reserve during the six-month period ended July 2, 2000 and Cypress’s 1997 restructuring expense and charges taken against the reserve from the date the restructuring commenced through July 2, 2000 respectively. The actual liquidation of substantially all of the impaired assets was completed in November 1998. The balance of the reserve remaining was reversed and taken as a restructuring credit in Q2 2000 when it was determined that no outstanding commitments existed.


Balance
January 2,
2000

Utilized
Credits
Balance
July 2,
2000

(In thousands)
Operating lease costs(1)   $506   $(21 ) $(485 ) $ —  


1997
Restructuring
Expense

Utilized
Credits
Balance
July 2,
2000

(In thousands)
Operating lease costs(1)   $3,615   $(3,130 ) $(485 ) $ —  
Severance and other employee related charges(1)  207   (207 )    
Transaction and other costs(1)  2,164   (2,164 )    

          Total  $5,986   $(5,501 ) $(485 ) $ —  

__________
(1) Classified on the Condensed Consolidated Balance Sheet as part of accrued liabilities.



Note 13 — Equity and Debt Transactions

During the first quarter of fiscal year 2000, Cypress filed a registration statement on Form S-3 with the Securities and Exchange Commission. Under this shelf registration, which was effective February 8, 2000, as amended by a post-effective amendment thereto effective March 7, 2000, Cypress can, through January 2002, sell any combination of debt securities, preferred stock and common stock in one or more offerings up to a total amount of $400.0 million. The shelf registration statement allows Cypress flexibility to raise funds from the offering of debt securities, common stock, preferred stock or a combination thereof, subject to market conditions and Cypress’s capital needs. Pursuant to this shelf registration statement, on June 26, 2000, Cypress completed a $287.5 million registered-placement of 5-year convertible subordinated notes. The notes are due in the year 2005, with a coupon rate of 3.75% and an initial conversion premium of 27%. The notes are convertible into approximately 4.6 million shares of common stock and are callable by Cypress no earlier than July 5, 2003. Net proceeds were $279.6 million, after issuance costs of $7.9 million.

During the fourth quarter of 1998, Cypress filed a registration statement on Form S-3 with the Securities and Exchange Commission. Under this shelf registration statement, which was declared effective in the first quarter of 1999, Cypress could, through March 2001, sell any combination of debt securities, preferred stock and common stock in one or more offerings up to a total amount of $300.0 million. Pursuant to the shelf registration statement, on March 29, 1999, Cypress sold 7.2 million shares of common stock. Cypress received approximately $33.8 million in proceeds, net of issuance costs, from the sale of these shares. Cypress filed an additional registration statement on Form S-3, pursuant to Rule 462(b) under the Securities Act, to register securities in excess of the $300.0 million available under the shelf registration statement. On January 25, 2000, Cypress completed a $283.0 million registered-placement of 5-year convertible subordinated notes. The notes are due in the year 2005, with a coupon rate of 4.0% and an initial conversion premium of 28.5%. The notes are convertible into approximately 6.1 million shares of common stock and are callable by Cypress no earlier than February 5, 2003. Net proceeds were $275.2 million, after issuance costs of $7.8 million.

Note 14 — Legal Matters

The semiconductor industry has experienced a substantial amount of litigation regarding patent and other intellectual property rights. From time to time, Cypress has received, and may receive in the future, communications alleging that its products or its processes may infringe on product or process technology rights held by others. Cypress is currently, and may in the future be, involved in litigation with respect to alleged infringement by Cypress of another party’s patents. In the future, Cypress may be involved with litigation to:


Enforce its patents or other intellectual property rights.
Protect its trade secrets and know-how.
Determine the validity or scope of the proprietary rights of others.
Defend against claims of infringement or invalidity.

Such litigation has in the past and could in the future result in substantial costs and diversion of management resources. Such litigation could also result in payment of substantial damages and/or royalties or prohibitions against utilization of essential technologies, and could have a material adverse effect on Cypress’s business, financial condition and results of operations.

On June 12, 2000, Cypress filed a complaint in the Superior Court of California, against Altera Corporation for tortious interference with existing contractual relations, tortious interference with prospective economic relations, misappropriation of trade secrets and unfair competition. The complaint arises from Altera’s interference with a multi-year agreement to collaborate on research and development between Cypress and Right Track CAD Corporation. Cypress believes that it will ultimately prevail in this matter. While no assurance can be given regarding the outcome of this action, Cypress believes that the final outcome of the matter will not have a material effect on Cypress’s consolidated financial position or results of operations. However, because of the nature and inherent uncertainties of litigation, should the outcome of this action be unfavorable, Cypress may be required to pay legal fees and other expenses, which is not expected to have a material adverse effect on Cypress’s financial position and results of operations.




During 1998, EMI Group of North America, Inc. (“EMI”) filed suit against Cypress in the Federal Court in Delaware, claiming that Cypress infringed on four patents owned by EMI. Cypress and EMI entered into a license agreement in February 1999, for one of the four patents in the lawsuit. EMI withdrew two of the four patents from the lawsuit, including the patent related to the licensing agreement. The case involving the two remaining patents went to trial in October 1999. The jury ruled in favor of Cypress claiming that none of the patents were infringed by Cypress and that each asserted claim was invalid due to prior art and physical impossibility (i.e. the patents require a step that is physically impossible to perform). On July 7, 2000, the court ruled on post-trial motions filed by EMI, upholding the jury’s findings that the EMI patents are invalid and that Cypress does not infringe the EMI patents. EMI may appeal these rulings. Should EMI appeal the decision of the Federal Court, Cypress intends to defend itself vigorously. However, should the outcome of this action be unfavorable, Cypress’s business, financial condition and results of operations could be materially and adversely affected.

In January 1998, an attorney representing the estate of Mr. Jerome Lemelson contacted Cypress and charged that Cypress infringed certain patents owned by Mr. Lemelson. On February 26, 1999, the Lemelson attorneys sued Cypress and 87 other companies for infringement of 16 patents. Cypress has reviewed and investigated the allegations in the complaint and Cypress believes that the suits are without merit. Cypress will vigorously defend itself in this matter. While no assurance can be given regarding the outcome of this action, Cypress believes that the final outcome of the matter will not have a material effect on Cypress’s consolidated financial position or results of operations. However, because of the nature and inherent uncertainties of litigation, should the outcome of this action be unfavorable, Cypress may be required to pay damages and other expenses, which could have a material adverse effect on Cypress’s financial position and results of operations.

In June 1997, Cypress commenced a declaratory judgment action in the United States District Court for the District of Nevada against the Li Second Family Trust (“the Trust”). In this action, Cypress asked for declaratory relief to the effect that an U.S. patent relating to a part of the process for manufacturing semiconductors is unenforceable, invalid and not infringed by Cypress. The Trust has counter-claimed for patent infringement on the same patent, alleging such patent covers oxide-isolated integrated circuits. In May 1999, in a related case, the United States District Court for the Eastern District of Virginia ruled that the patent is unenforceable due to inequitable conduct by Dr. Li and his attorneys in obtaining the patent. Cypress believes it has meritorious defenses to the counter-claim and intends to defend itself vigorously. While no assurance can be given regarding the outcome of this action, Cypress believes that the final outcome of the matters will not have a material effect on Cypress’s consolidated financial position or results of operations. However, should the outcome of this action be unfavorable, Cypress’s business, financial condition and results of operations could be materially and adversely affected.

On October 2, 1997, Cypress filed an action against Kevin Yourman, Joseph Weiss, and their associated law offices in the Superior Court of California (“Superior Court”) in Santa Clara County for malicious civil prosecution in the underlying securities fraud actions initiated by Messrs. Yourman and Weiss in 1992. The underlying securities fraud actions were dismissed because no officer of Cypress made any actionable false or misleading statements or omissions. An appeal affirmed the lower court’s finding that Messrs. Yourman and Weiss failed to put forth evidence showing a genuine issue of fact with regard to any statements by Cypress’s officers. On May 4 1999, the Superior Court granted a summary judgment motion by Messrs. Yourman and Weiss, holding that Messrs. Yourman and Weiss had probable cause to bring the underlying litigation. Cypress is appealing the decision. However, the results of litigation are unpredictable. Cypress believes that this action, regardless of its outcome, will have little, if any effect on Cypress’s consolidated financial position or results of operations.




Note 15 — Comprehensive Income

In fiscal 1997, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 130, “Reporting Comprehensive Income”. Comprehensive income refers to the change in the equity of a company during a period from transactions except those resulting from investments by owners and distributions to owners. Cypress adopted this statement as of the first quarter of 1998 and has determined that it does not have any components of other comprehensive income.

Note 16 — Segment Reporting

Cypress has two reportable segments, Memory Products and Non-memory Products. The Memory Products segment includes Static Random Access Memories (“SRAMs”) and multichip modules. The Non-memory Products segment includes programmable logic products, data communication devices, interface products, computer products, non-volatile memory products and wafers manufactured by the foundry. Cypress evaluates the performance of its two segments based on profit or loss from operations before income taxes, excluding nonrecurring gains and losses.

While both Memory and Non-Memory segments primarily serve the communications marketplace, the segments differ in functionality. Memory Products are delineated by their ability to store and retrieve information. Non-Memory product functionality relates primarily to logic, timing, data transfer and routing of information. The desired functionality will often determine the price, margin and point of manufacture of a particular product in a market segment.

The tables below set forth information about the reportable segments for three- and six-month periods ended July 2, 2000 and July 4, 1999. Cypress does not allocate income taxes or non-recurring items to segments. In addition, segments do not have significant non-cash items other than depreciation and amortization in reported profit or loss.

Business Segment Net Revenues

Three Months Ended
Six Months Ended
July 2,
2000

July 4,
1999

July 2,
2000

July 4,
1999

(In thousands)
Memory   $141,331   $71,890   $263,997   $137,676  
Non-memory  159,503   98,935   301,078   192,442  

  Total consolidated revenues  $300,834   $170,825   $565,075   $330,118  


Business Segment Profit (Loss)

Three Months Ended
Six Months Ended
July 2,
2000

July 4,
1999

July 2,
2000

July 4,
1999

(In thousands)
Memory   $36,727   $(7,715 ) $55,369   $(19,616 )
Non-memory  49,709   21,952   92,463   42,723  
Acquisition and merger costs  (7,592 ) (6,070 ) (11,801 ) (6,102 )
Restructuring credits  485   100   485   100  
Interest income and other  12,315   3,871   26,717   7,149  
Interest expense  (5,501 ) (2,465 ) (10,067 ) (4,790 )

Income before provision for 
   income taxes  $86,143   $9,673   $153,166   $19,464  



Note 17 — Recent Accounting Pronouncements

In April 2000, the Financial Accounting Standards Board issued FASB interpretation of No. 44, Accounting for Certain Transactions Involving Stock Compensation, an interpretation of APB Opinion No. 25. Among other issues, this interpretation clarifies the definition of employees for purposes of applying Opinion No. 25, the criteria for determining whether a plan qualifies as a non-compensatory plan, the accounting consequence of various modifications to the terms of a previously fixed stock option or award and the accounting for an exchange of stock compensation awards in a business combination. This interpretation is effective July 1, 2000, but certain conclusions in the interpretation cover specific events that occur after either December 15, 1998 or January 12, 2000. To the extent that this interpretation covers events occurring during the period after December 15, 1998, or January 12, 2000, but before the effective date of July 1, 2000, the effect of applying this interpretation is recognized on a prospective basis from July 1, 2000. We are currently reviewing stock grants to determine the impact, if any, that may arise from implementation of this interpretation, although we do not expect the impact, if any, to be material to our financial statements.

In December 1999, the staff of the Securities and Exchange Commission issued Staff Accounting Bulletin No. 101 (“SAB 101”) “Views on Selected Revenue Recognition Issues” which provides the staff’s views in applying generally accepted accounting principles to selected revenue recognition issues. Adoption of SAB 101 is required by the fourth quarter of fiscal 2000. Management has evaluated SAB 101 and believes that revenue recognition policies currently in place comply with SAB 101.

In June 1998, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 133, “Accounting for Derivative Instruments and Hedging Activities” (“SFAS 133”). SFAS 133 establishes a new model for accounting for derivatives and hedging activities and supercedes and amends a number of existing accounting standards. SFAS 133 requires that all derivatives be recognized in the balance sheet at their fair market value. In addition, corresponding derivative gains and losses should be either reported in the statement of operations and stockholders equity, depending on the type of hedging relationship that exists with respect to such derivatives. Adopting the provisions of SFAS 133, which will be effective in fiscal year 2001, are not expected to have a material effect on Cypress’s consolidated financial statements.

Note 18 — Subsequent Events

Merger with Silicon Light Machines

On July 25, 2000, Cypress announced the signing of a definitive agreement to acquire Silicon Light Machines, a privately held supplier of microelectromechanical systems (MEMS) technology applicable to fiber-optic networks and other applications. The merger, which is expected to close during the third quarter of fiscal 2000, is expected to be accounted for as a pooling of interests.




MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

For the Three and Six Months Ended July 2, 2000

All references are to Cypress’s fiscal quarters ended July 2, 2000 (“Q2 2000”), July 4, 1999 (“Q2 1999”), April 2, 2000 (“Q1 2000”), and April 4, 1999 (“Q1 1999”), unless otherwise indicated. This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including, but not limited to, statements as to future operating results and business plans of Cypress. We use words such as “anticipates”, “believes”, “expects”, “future”, “intends” and similar expressions to identify forward-looking statements. Actual results could differ materially from those projected in the forward-looking statements as a result of the factors set forth in “Factors Affecting Future Results” and elsewhere in this report.

Results of Operations

   Revenues

Revenues for three- and the six-month periods ended July 2, 2000 were $300.8 million and $565.1 million, respectively. Revenues for Q2 2000 increased $130.0 million or 76.1% compared to revenues of $170.8 million for Q2 1999. Revenues of $565.1 million for the six-month period ended July 2, 2000 were $235.0 million or 71.1% higher than the $ 330.1 million recognized in the comparable period of the prior fiscal year. Cypress derives its revenues from the sale of Memory Products and Non-memory Products. Below is a summary of revenues derived from the sale of Memory Products and Non-memory Products.


Three Months Ended
Six Months Ended
July 2,
2000

July 4,
1999

July 2,
2000

July 4,
1999

(In thousands)
Memory   $141,332   $71,928   $263,992   $137,714  
Non-memory  159,502   98,897   301,083   192,404  

  Total consolidated revenues  $300,834   $170,825   $565,075   $330,118  


Sales from Memory Products include Static Random Access Memories (“SRAMs”) and multichip modules. Revenues from the sale of Memory Products for Q2 2000 increased $69.4 million or 96.6% over revenues from the sale of these products for Q2 1999. When comparing revenues for the six months ended July 2, 2000 to the comparable period of the prior fiscal year, Memory Product revenues increased $126.3 million or 91.7%. The increases in Memory Product revenues as compared to the three- and six-month periods ended July 4, 1999 resulted from both higher average selling prices (“ASPs”) and an increase in unit sales. ASPs increased 42% and unit sales increased 55% comparing Q2 2000 to Q2 1999. ASPs increased 37% and unit sales increased 58% comparing the six-month periods ended July 4, 1999 and July 2, 2000. Revenue growth for memory products can be attributed to strong demand in the communications markets. Sales of new products, such as the 1, 2, and 4 Mbit MoBL (“More Battery Life”) SRAMs, have resulted in higher unit sales and higher ASPs.

Non-memory Products include computer products, interface products, data communication devices, non-volatile memory devices and programmable products. Non-memory Products also include foundry revenues. Foundry revenues represent the sale of wafers to customers. Revenues from the sale of Non-memory Products increased $60.6 million or 61.2% comparing Q2 2000 to Q2 1999. The growth related primarily to increases in sales of data communication devices of $32.1 million, interface products of $15.3 million, programmable products of $7.8 million, and timing technology products of $7.5 million. These increases were partially offset by decreases in foundry revenue of $0.5 million and non-volatile memory of $1.6 million. The primary factors contributing to the increase in data communication devices was higher unit sales and higher ASPs, particularly in the specialty memory and channel line of products. For the six-month period July 2, 2000 as compared to the same period in the previous fiscal year, revenues from the sale of Non-memory Products increased $108.7 or 56.5%. The increase from the six-month period ended July 4, 1999 to the comparable period in fiscal 2000 related primarily to increases in sales of data communication devices of $55.5 million, interface products of $31.5 million, programmable products of $14.7 million, and timing technology products of $12.2 million. These increases were partially offset by decreases in foundry revenue of $2.5 million and non-volatile memory of $2.8 million. The primary factors contributing to the increase in data communication devices was higher unit sales and higher ASPs, particularly in the specialty memory and channel line of products. The increase in revenues for interface products can be attributed to higher unit sales due to the growing market conversion to Universal Serial Bus (“USB”) peripheral products. The net increase in programmable logic devices was a result of higher unit sales and higher ASPs. The revenue growth in timing technology products between the first six-months of fiscal 1999 and 2000 was primarily a result of the increased unit sales due to greater acceptance of Cypress’s clock products.




The semiconductor industry is highly cyclical and subject to significant downturns as a result of a variety of risk factors, including, but not limited to, diminished product demand, production over-capacity and accelerated erosion of ASPs. Revenues have continued to be impacted by fluctuations in ASPs. Should ASPs erode at a rate greater than anticipated, gross margins could be seriously harmed. Cypress continues to introduce new products and new methods of reducing manufacturing costs in order to mitigate the effects of changes in ASPs on its gross margins.

   Cost of Revenues

Cost as a percent of revenue decreased to 44.9% for Q2 2000 as compared to 56.0% in Q2 1999. For the six-month periods ended July 2, 2000 and July 4, 1999, cost as a percent of revenue was 47.1% and 57.2%, respectively. This improvement was brought about by a series of factors including increased value-added products which command higher prices and result in higher margin, strong unit demand, a stable pricing environment and continued cost reduction activities. Since 1998, Cypress has changed its product focus more towards solutions in the data-communications market. This change has resulted in new product offerings having a high value added component. This is in contrast to our prior focus of building larger and faster commodity memory devices. A prime example of this is our MoBL SRAM. The end result of Cypress’ new focus is that selling prices and the resulting margins are generally higher than in prior periods. The communications focus has also resulted in increased unit demand from our customers. Unit demand has further increased due to a strong semiconductor market characterized by tightness in supply even in older commodity products. This has enabled Cypress to enjoy improved factory utilization and absorption over 1999 and into 2000. The tight supply and the offering of more products that are not purely commodity driven has resulted in stable pricing in a business that usually endures price declines over a product-life cycle. Cypress has continued its significant investment in process technology, which has reduced the line widths, and resulting die size. Extensive use of Cypress’s .25 micron technology has led to significant cost reductions particularly in the memory segment. While Cypress is optimistic about its abilities to continue the trend of improving margins, there are significant risk factors, described later in this report that could adversely impinge upon profit margins.

In March 1998, Cypress announced restructuring activities for its domestic wafer fabrication facilities and offshore back-end manufacturing operations. Activities completed to date have increased Cypress’s manufacturing efficiencies and decreased cost of revenues. Cost of revenues as a percent of revenues may be impacted by a variety of factors including but not limited to the following:


Product mix;
Factory capacity and utilization;
Manufacturing yields;
Availability of certain raw materials;
Terms negotiated with third-party contractors; and
Foreign currency fluctuations.

These and other factors could cause a significant increase or decrease on our gross margin in future periods.

   Research &Development

Research and development (“R&D”) expenditures for Q2 2000 were $42.7 million or 14.2% of revenues, compared to $34.1 million or 20.0% of revenues for Q2 1999. R&D costs incurred in the six months ended July 2, 2000 were $81.1 million or 14.4% or revenues compared to $66.2 million or 20.1% of revenues for the comparable period in fiscal 1999. Even though absolute spending in R&D was $8.6 million higher comparing Q2 2000 to Q2 1999, R&D expenditures as a percentage of revenues declined as the increase in revenues far exceeded the increase in spending. The $8.6 million increase in R&D costs from Q2 1999 to Q2 2000 relates primarily to costs associated with new product development at Cypress’s design centers and to the continued development of more advanced process technologies. These factors also contributed to the $14.9 million increase in R&D expenditures from the first six months of fiscal 1999 to the first six months of fiscal 1999.




Cypress expects spending for R&D will continue to increase as Cypress continues its efforts to accelerate the development of new products and migration to more advanced process technologies. Cypress is continuing to explore new markets and improve its design and process technologies in an effort to increase revenues and reduce costs. The foregoing statements regarding Cypress’s R&D spending efforts are forward-looking.

   Selling, General and Administrative

Selling, general and administrative (“SG&A”) expenses for Q2 2000 were $36.5 million or 12.1% of revenues, compared to $26.9 million or 15.7% of revenues for Q2 1999. SG&A costs incurred for the six months ended July 2, 2000 were $70.1 million or 12.4% of revenues compared to $51.8 million or 15.7% of revenues for the same period in 1999. Even though absolute spending in SG&A was $9.6 million higher comparing Q2 2000 to Q2 1999 and $18.3 million higher comparing the six months ended July 2, 2000 with the same period in 1999, SG&A expenditures as a percentage of revenues declined as the increase in revenues far exceeded the increase in spending. The increase in SG&A costs of $9.6 million from Q2 1999 to Q2 2000 and $18.3 million from the six month periods ended July 4, 1999 to July 2, 2000 relate primarily to higher commission expenses, salary and related benefit costs, legal fees, and expenses for other professional services. The change in all other SG&A expenses from 1999 to 2000 was not significant.

With the exception of variable spending such as incentive bonuses and commissions, Cypress expects recurring SG&A spending to remain relatively constant. The foregoing statement regarding Cypress’s SG&A spending efforts is forward-looking.

   Acquisition and Merger Costs

During Q2 2000, Cypress recorded aggregate merger-related transaction costs of $7.6 million. The $7.6 million of costs incurred in Q2 2000 relate to the amortization of intangible assets recorded during the 1999 acquisitions of Anchor Chips, Arcus, and the MAX 5000 Programmable Logic Device (“PLD”) product line from Altera, and other acquisition costs related to the merger with Alation and the acquisition of RadioCom in Q2 2000. Acquisition costs of $3.6 million related to Alation and RadioCom and consist primarily of deferred compensation, legal, accounting and investment banking fees. During Q2 1999, Cypress recorded aggregate merger-related transaction costs of $6.1 million related primarily to the acquisition of Anchor Chips and Arcus. These charges consist primarily of investment banking and other professional fees.

   1998 Restructuring Costs

In March 1998, Cypress recorded a one-time, pre-tax restructuring charge of $57.1 million related to the impairment of assets ($46.4 million), reduction in work force ($4.8 million), and other transaction costs ($5.9 million). The restructuring entailed:


The shutdown of Fab 3 located in Bloomington, Minnesota and consolidation of parts of Fab 3 operations with other operations of Cypress.
The discontinuance of the 0.6-micron 256K SRAM production in Fab 2 located in Texas.
The conversion of an existing research and development fab located in San Jose (“Fab 1”) to eight-inch capability in order to be compatible with the state of the art eight-inch Minnesota manufacturing facility.
The transfer of Cypress’s test operations from its subcontractor, Alphatec, in Thailand to Cypress’s production facility in the Philippines.

The restructuring activities described above included the termination of approximately 850 personnel, primarily from manufacturing, both at Cypress and at Alphatec.

During Q2 1998, in conjunction with the closure of Fab 3, Cypress established a reserve for $1.4 million to cover severance costs associated with the reduction of work force at that location. This was based on the anticipated level of payments that would be made to personnel included in the work force reduction. As a part of a review of inventory, it was noted that Cypress required an additional reserve of $0.5 million to cover inventory that was written off. This related to a change in estimate regarding inventory that had been previously reserved.




Restructuring activities associated with Fabs 2 and 3 were completed in May and July 1998, respectively, consistent with Cypress’s restructuring schedule except for the disposal of equipment. Fab 1 restructuring was not completed in January 1999 as originally planned. Cypress is in the process of converting its R&D wafer facility in San Jose to eight-inch capability and expects to have the conversion completed by December 2000. The Alphatec consolidation and transfer activity was completed in January 1999, one month later than originally planned.

   1999 Restructuring Credits

During Q1 1999, Cypress reversed $3.7 million of previously provided restructuring costs. $2.2 million of severance and other employee related charges and $0.3 million for the provision for phase-down and consolidation of manufacturing facilities were reversed in conjunction with the completion of the Alphatec restructuring activities. $0.5 million for other fixed asset related charges was reversed based on the determination that a portion of the fixed asset removal costs accrual would not be required. These reversals related to Cypress’s 1998 restructuring activities. Cypress also reversed a $0.7 million reserve for fixed asset installation costs related to its 1996 restructuring activities which was no longer required.

   Interest Expense

Interest expense was $5.5 million and $10.1 million during the three and the six month periods ended July 2, 2000 respectively, compared to $2.5 million and $4.8 million for the three and the six month periods ended July 4, 1999. Interest expense is primarily associated with the 6.0% Convertible Subordinated Notes, issued in September 1997 and due in 2002, the 4.0% Convertible Subordinated Notes, issued in January 2000 and due in 2005, and the 3.75% Convertible Subordinated Notes, issued in June 2000 and due in 2005. The increase of $3.0 million for Q2 1999 relates primarily to the increase in interest due to the January 2000 issuance of the 4.0% Convertible Subordinated Notes. The $5.3 million increase from the six months ended July 4, 1999 relates primarily to the increase in interest due to the January 2000 issuance of the 4.0% Convertible Subordinated Notes.

   Interest Income and Other

Net interest income and other was $12.3 million and $26.7 million for the three- and six-month periods ended July 2, 2000, respectively, compared to $3.9 million and $7.1 million for the three- and six-month periods ended July 4, 1999. Net interest income and other includes interest income, amortization of bond issuance costs, foreign exchange gains and losses and other non-recurring items. The $8.4 million increase from Q2 1999 to Q2 2000 relates primarily to higher interest income due to increased cash balances, primarily resulting from new convertible note issuances in January and June 2000, and higher investment yields. The $19.6 million increase from the first six months of fiscal 1999 to the first six months of fiscal 2000 relates primarily to higher interest income due to increased cash balances, primarily resulting from new convertible note issuances in January and June 2000, and higher investment yields. The six-month period ended July 2, 2000 also includes a $5.0 million non-recurring gain related to the sale of the FCT business.

   Taxes

Cypress’s effective tax rates for Q2 2000 and Q2 1999 were 23.8% and 12.5%, respectively, resulting in an income tax expense of $20.5 million and $1.2 million, respectively. The increase in the effective tax rate from Q2 1999 to Q2 2000 can be attributed to non-deductible in-process research and development charges and merger costs. Cypress’s effective tax rates for Q2 2000 and Q2 1999, excluding non-deductible in-process research and development charges and merger costs, were 22.0 % and 5.0 %, respectively. Cypress’s effective rate varies from the U.S. statutory rate due to non-deductible in-process research and development charges and merger costs offset by utilization of loss carryovers, earnings of foreign subsidiaries taxed at lower rates and tax credits.

During 1998, the United States Internal Revenue Service began an examination of tax returns for fiscal years 1994 through 1996. The examination concluded in June 2000. The outcome of the examination did not have a material effect on Cypress’s consolidated financial position or results of operations.

   Net Income and Net Income Per Share

Net income for Q2 2000 was $65.6 million or $0.49 per share on a diluted basis, compared to a net income of $8.5 million or $0.08 per share, on a diluted basis for Q2 1999. Net income for the six months ended July 2, 2000 was $117.7 million or $0.89 per share on a diluted basis, compared to net income of $17.3 million or $0.16 per share on a diluted basis for the six months ended July 4, 1999.




   Earnings Before Goodwill

Cypress reported basic earnings before goodwill (“EBG”) and diluted EBG. EBG refers to earnings excluding pretax acquisition and restructuring related charges and credits, in-process research and development costs, transaction costs and amortization of intangible assets, net of tax. These charges and credits are excluded from the computation of EBG and are collectively referred to as goodwill by Cypress. We have presented EBG as a measure of our operating results, but EBG is not intended to replace operating income or net income as an indicator of operating performance, or to replace cash flow as a measure of liquidity, because EBG is not a concept under generally accepted accounting principles. Also, our calculation of EBG may not be comparable to EBG as calculated by other companies. The table below reconciles basic and diluted net income per share to basic and diluted earnings before goodwill per share, respectively.

Reconciliation of basic net income per share to basic earnings before goodwill:


Three Months Ended
Six Months Ended
July 2,
2000

July 4,
1999

July 2,
2000

July 4,
1999

(In thousands)
Basic net income per share   $0.56   $0.08   $ 1.01   $ 0.17  
Goodwill & Acquisition costs net of taxes per share .  $0.06   $0.05   $ 0.08   $ 0.09  
Non-recurring gain on sale of FCT per share  $   —   $   —   $(0.03 ) $    —  
Restructuring credits net of taxes per share  $   —   $   —   $    —   $(0.04 )

Basic earnings before goodwill per share  $0.62   $0.13   $ 1.06   $ 0.22  



Reconciliation of diluted net income per share to diluted earnings before goodwill:


Three Months Ended
Six Months Ended
July 2,
2000

July 4,
1999

July 2,
2000

July 4,
1999

(In thousands)
Diluted net income per share   $0.49   $0.08   $ 0.89   $ 0.16  
Goodwill & Acquisition costs net of taxes per share  $0.05   $0.05   $ 0.07   $ 0.09  
Non-recurring gain on sale of FCT per share  $   —   $   —   $(0.03 ) $    —  
Restructuring credits net of taxes per share  $   —   $   —   $    —   $(0.04 )

Diluted earnings before goodwill per share  $0.54   $0.13   $ 0.93   $ 0.21  



Liquidity and Capital Resources

Cypress’s cash, cash equivalents and short-term investments totaled $840.4 million at July 2, 2000, a $559.4 million increase from the end of fiscal 1999.

During the three- and six-month periods ended July 2, 2000, Cypress purchased $87.6 million and $151.8 million in capital equipment, respectively, compared to $12.3 million and $41.5 million in the same periods in fiscal 1999. Cypress purchased equipment for its domestic wafer fabrication plants, its test and assembly facility in the Philippines and its design and technology groups. Equipment purchased for its fabs is expected to improve wafer manufacturing capacity and capabilities as Cypress implements new technologies, including its 0.16- and 0.25-micron processes. A majority of the equipment purchased was to increase the capacity and capability of Fab 4 located in Minnesota. Equipment purchased for the Philippines was used to increase manufacturing capacity and tool certain packaging capabilities. Purchases of capital equipment for the technology group are expected to enhance and accelerate research and development capabilities. Cypress continues its efforts to increase its manufacturing capabilities and capacity and to enhance its research and development capabilities. Capital expenditures for the remainder of 2000 are expected to be approximately $228.2 million.

On January 31, 2000, Cypress filed a registration statement on Form S-3 with the Securities and Exchange Commission. Under this shelf registration, which was effective February 8, 2000, as amended by a post-effective amendment thereto effective March 7, 2000, Cypress can, through January 2002, sell any combination of debt securities, preferred stock and common stock in one or more offerings up to a total amount of $400.0 million. The shelf registration statement allows Cypress flexibility to raise funds from the offering of debt securities, common stock, preferred stock or a combination thereof, subject to market conditions and Cypress’s capital needs. Pursuant to this shelf registration statement, on June 26, 2000, Cypress completed a $287.5 million register-placement of 5-year convertible subordinated notes. The notes are due in the year 2005, with a coupon rate 3.75% and an initial conversion premium of 27%. The notes are convertible into approximately 4.6 million shares of common stock and are callable by Cypress no earlier than July 5, 2003. Net proceeds were $279.6 million, after issuance costs of $7.9 million.




During the fourth quarter of 1998, Cypress filed a registration statement on Form S-3 with the Securities and Exchange Commission. Under this shelf registration statement, which was declared effective in the first quarter of 1999, Cypress could, through March 2001, sell any combination of debt securities, preferred stock and common stock in one or more offerings up to a total amount of $300.0 million. Pursuant to the shelf registration statement, on March 29, 1999, Cypress sold 7.2 million shares of common stock. Cypress received approximately $33.8 million in proceeds, net of issuance costs, from the sale of these shares. Cypress filed an additional registration statement on Form S-3, pursuant to Rule 462(b) under the Securities Act, to register securities in excess of the $300.0 million available under the shelf registration statement. On January 25, 2000, Cypress completed a $283.0 million registered-placement of 5-year convertible subordinated notes. The notes are due in the year 2005, with a coupon rate of 4.0% and an initial conversion premium of 28.5%. The notes are convertible into approximately 6.1 million shares of common stock and are callable by Cypress no earlier than February 5, 2003. Net proceeds were $275.2 million, after issuance costs of $7.8 million.

In March 1999, Cypress announced a program whereby all U.S. employees were offered loans to facilitate the exercise of vested stock options. The loans, including interest, are due at the earlier of three days following the sale of the shares, within thirty days of the date the individual ceases to be an employee of Cypress or 3 years from the grant date of the loan. The loans bear interest and are secured by Cypress common shares. At July 2, 2000, loans receivable under this program totaled $2.5 million.

In fiscal years 1997 and 1998, the Board of Directors authorized the repurchase of up to 14.0 million shares of Cypress’s common stock. Through January 3, 1999, 8.1 million shares had been repurchased under this entire program for $67.5 million. On February 25, 1999, the Board of Directors terminated the stock repurchase program. The unsold repurchased shares were and are expected to continue to be used for option exercises under Cypress’s 1994 Stock Option Plan and stock purchases under the Employee Stock Purchase Plan. During 1998, Cypress reissued 1.8 million shares of common stock under such plans. During fiscal 1999, Cypress reissued a total of 8.3 million shares in relation to the stock offering described above and in conjunction with the 1994 Stock Option Plan and Employee Purchase Plan. Such shares had been repurchased under the 1997/1998 plan and repurchase programs prior to 1997.

Cypress believes that existing cash and equivalents as well as cash from operations will be sufficient to meet present and anticipated working capital requirements for at least the next twelve months. Cypress’s need for further capacity and resulting capital expansion may result in the need to raise additional capital through debt or equity financing. Conversely, Cypress’s operating results may be adversely impacted by various risk factors causing Cypress to raise additional monies. Although additional financing may be required, Cypress may not be able to obtain the capital or satisfactory terms.

Factors Affecting Future Results

   Risk Factors

Except for the historical information contained herein, the discussion in this Form 10-Q report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, but not limited to, statements as to the future operating results and business plans of Cypress, that involve risks and uncertainties. We use words such as “anticipate”, “believes”, “expects”, “future”, “intends” and similar expressions to identify forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements for any reason, including the risks described below and elsewhere in this Form 10-Q. If any of the following risks actually occur, our business, financial condition and operating results could be seriously harmed.

Our future operating results are unusually likely to fluctuate and therefore may fail to meet expectations.

Our operating results have varied widely in the past, and may continue to fluctuate in the future. In addition, our operating results may not follow any past trends. Our future operating results will depend on many factors and may fluctuate and fail to meet our expectations or those of others for a variety of reasons, including the following:




the intense competitive pricing pressure to which our products are subject, which can lead to rapid and unexpected declines in average selling prices;
the complexity of our manufacturing processes and the sensitivity of our production costs to declines in manufacturing yields, which make yield problems both possible and costly when they occur; and
the need for constant, rapid new product introductions which present an ongoing design and manufacturing challenge, which can be significantly impacted by even relatively minor errors, and which may result products never achieving expected market demand.

As a result of these or other factors we could fail to achieve our expectations as to future revenues, gross profit and income from operations. Any downward fluctuation or failure to meet expectations will likely adversely affect the value of your investment in Cypress.

In addition, because we recognize revenues from sales to our domestic distributors only when these distributors make a sale to customers, we are highly dependent on the accuracy of their resale estimates. The occurrence of inaccurate estimates also contributes to the difficulty in predicting our quarterly revenue and results of operations.

We face periods of industry-wide semiconductor over-supply which harm our results.

The semiconductor industry has historically been characterized by wide fluctuations in the demand for, and supply of, semiconductors. These fluctuations have helped produce many occasions when supply and demand for semiconductors have not been balance. In the past, these industry-wide fluctuations in demand, which have resulted in under-utilization of our manufacturing capacity, have harmed our operating results. In some cases, industry downturns with these characteristics have lasted more than a year. If these cycles continue, they will seriously harm our business, financial condition and results of operations.

Our financial results could be seriously harmed if the markets in which we sell our products do not grow.

Our continued success depends in large part on the continued growth of various electronics industries that use our semiconductors, including the following industries:


data communications and telecommunications equipment;
computers and computer related peripherals;
automotive electronics;
industrial controls;
customer electronics equipment; and
military equipment.

A significant portion of our products is incorporated into data communications and telecommunication end products. Any decline in the demand for networking applications, mass storage, telecommunications, cellular base stations, cellular handsets and other personal communication devices which incorporate our products could seriously harm our business, financial condition and operating results. In addition, certain of our products, including Universal Serial Bus microcontrollers, high-frequency clocks and static RAMs, are incorporated into computer and computer-related products, which have historically experienced significant fluctuations in demand. We may also be seriously harmed by slower growth in the other markets in which we sell our products.

We are affected by a general pattern of product price decline and fluctuations, which can harm our business.

Even in the absence of an industry downturn, the average selling prices of our products have historically decreased during the products’ lives, and we expect this trend to continue. In order to offset these average selling price decreases, we attempt to decrease manufacturing costs of our products, and to introduce new, higher priced products that incorporate advanced features. If our efforts are not successful or do not occur in a timely manner, or if our newly introduced products do not gain market acceptance, our business, financial condition and results of operations could be seriously harmed.




In addition to following the general pattern of decreasing average selling prices, the selling prices for certain products, particularly commodity static RAM products, fluctuate significantly with real and perceived changes in the balance of supply and demand for these products. Growth in worldwide supply of static RAMs in recent periods resulted in a decrease in average selling prices for such products. If we are unable to decrease per unit manufacturing costs faster than a rate equal to or faster than the rate at which average selling prices continue to decline, our business, financial condition and results of operations will be seriously harmed. Furthermore, we expect our competitors to invest in new manufacturing capacity and achieve significant manufacturing yield improvements in the future. These developments could dramatically increase worldwide supply of static RAM products and result in associated downward pressure on prices.

We may be unable to adequately protect our intellectual property rights, and may face significant expenses as a result of ongoing or future litigation.

Protection of intellectual property rights is essential to keep others from copying the innovations that are central to our existing and future products. Consequently, we may become involved in litigation to enforce our patents or other intellectual property rights, to protect our trade secrets and know-how, to determine the validity or scope of the proprietary rights of others, or to defend against claims of invalidity. This kind of litigation can be expensive, regardless of whether we win or lose.

Also, we are now and may again become involved in litigation relating to alleged infringement by us of others’ patents or other intellectual property rights. This kind of litigation is frequently expensive to both the winning party and the losing party and takes up significant amounts of management’s time and attention. In addition, if we lose such a lawsuit, a court could require us to pay substantial damages and/or royalties, or prohibit us from using essential technologies. For these and other reasons, this kind of litigation could seriously harm our business, financial condition and results of operations. Also, although we may seek to obtain a license under a third party’s intellectual property rights in order to bring an end to certain claims or actions asserted against us, we may not be able to obtain such a license on reasonable terms or at all.

We have entered into technology license agreements with third parties that give those parties the right to use patents and other technology developed by us, and that give us the right to use patents and other technology developed by them. We anticipate that we will continue to enter into these kinds of licensing arrangements in the future. It is possible, however, that licenses we want will not be available to us on commercially reasonable terms. If we lose existing licenses to key technology, or are unable to enter into new licensing agreements, which we deem important, our business, financial condition and results of operations could be seriously harmed.

It is critical to our success that we are able to prevent competitors from copying our innovations, we therefore intend to continue to seek patent, trade secret and mask work protection for our semiconductor manufacturing technologies. The process of seeking patent protection can be long and expensive, and we cannot be certain that any currently pending or future applications will actually result in issued patents, or that, even if patents are issued, that they will be of sufficient scope or strength to provide meaningful protection or any commercial advantage to us. Furthermore, others may develop technologies that are similar or superior to our technology or design around the patents we own.

We also rely on trade secret protection for our technology, in part through confidentiality agreements with our employees, consultants and third parties. However, these parties may breach these agreements, and we may not have adequate remedies for any breach. Also, others may come to know about or determine our trade secrets through a variety of methods. In addition, the laws of certain territories in which we develop, manufacture or sell our products may not protect our intellectual property rights to the same extent as the laws of the United States.

Our financial results could be adversely impacted if we fail to develop, introduce and sell new products or fail to develop and implement new manufacturing technologies.

Like many semiconductor companies, which frequently operate in a highly competitive, quickly changing environment marked by rapid obsolescence of existing products, our future success depends on our ability to develop and introduce new products which customers choose to buy. We introduce significant numbers of new products each year, which are an important source of revenue for us. If we fail to compete and introduce new product designs in a timely manner or are unable to manufacture products according to the requirements of these designs (discussed more below), or if our customers do not successfully introduce new systems or products incorporating ours, or market demand for our new products does not exist as anticipated, our business, financial condition and results of operations could be seriously harmed.




For Cypress and many other semiconductor companies, introduction of new products is a major manufacturing challenge. The new products the market requires tend to be increasingly complex, incorporating more functions and operating at greater speed than prior products. Increasing complexity generally requires smaller features on a chip. This makes manufacturing new generations of products substantially more difficult than prior products. Ultimately, whether we can successfully introduce these and other new products depends on our ability to develop and implement new ways of manufacturing semiconductors. If we are unable to design, develop, manufacture, market and sell new products successfully, our business, financial condition and results of operations would be seriously harmed.

Interruptions in the availability of raw materials can seriously harm our financial performance.

Our semiconductor manufacturing operations require raw materials that must meet exacting standards. We generally have more than one source available for these materials, but there are only a limited number of suppliers capable of delivering certain raw materials that meet our standards. If we need to use other companies as suppliers, they must go through a qualification process. In addition, the raw materials we need for our business could become scarcer as worldwide demand for semiconductors increases. Interruption of our sources of raw materials could seriously harm our business, financial condition and results of operations.

Problems in the performance of other companies we hire to perform certain manufacturing tasks can seriously harm our financial performance.

A high percentage of our products are assembled, packaged and tested at our manufacturing facility located in the Philippines. We rely on independent subcontractors to assemble, package and test the balance of our products. This reliance involves certain risks, because we have less control over manufacturing quality and delivery schedules, whether these companies have adequate capacity to meet our needs and whether or not they discontinue or phase-out assembly processes we require. We cannot be certain that these subcontractors will continue to assemble, package and test products for us, and it might be difficult for us to find alternatives if they do not do so.

The complex nature of our manufacturing activities makes us highly susceptible to manufacturing problems and these problems can have substantial negative impact when they occur.

Making semiconductors is a highly complex and precise process, requiring production in a tightly controlled, clean environment. Even very small impurities in our manufacturing materials, difficulties in the wafer fabrication process, defects in the masks used to print circuits on a wafer or other factors can cause a substantial percentage of wafers to be rejected or numerous chips on each wafer to be nonfunctional. We may experience problems in achieving an acceptable success rate in the manufacture of wafers, and the likelihood of facing such difficulties is higher in connection with the transition to new manufacturing methods. The interruption of wafer fabrication or the failure to achieve acceptable manufacturing yields at any of our facilities would seriously harm our business, financial condition and results of operations. We may also experience manufacturing problems in our assembly and test operations and in the introduction of new packaging materials.

We may not be able to use all of our existing or future manufacturing capacity, which can negatively impact our business.

We have spent, and expect to continue to spend, significant amounts of money to upgrade and increase our wafer fabrication, assembly and test manufacturing capability and capacity. If we do not need some of this capacity and capability for any of a variety of reasons, including inadequate demand or a significant shift in mix of product orders making our existing capacity and capability inadequate or in excess of actual needs, our fixed costs per semiconductor produced will increase, which will harm us. In addition, if the need for more advanced products requires accelerated conversion to technologies capable of manufacturing semiconductors having smaller features, or requires the use of larger wafers, we are likely to face higher operating expenses and the need to write-off capital equipment made obsolete by the technology conversion, which could seriously harm our business and results of operations.

Our operations and financial results could be severely harmed by certain natural disasters.

Our headquarters, some manufacturing facilities and some of our major vendors’ facilities are located near major earthquake faults. If a major earthquake or other natural disaster occurs, we could suffer damages that could seriously harm our business, financial condition and results of operations.




Our business, results of operations and financial condition will be seriously harmed if we fail to successfully compete in our highly competitive industry and markets.

The semiconductor industry is intensely competitive. This intense competition results in a difficult operating environment for us and most other semiconductor companies that is marked by erosion of average selling prices over the lives of each product, rapid technological change, limited product life cycles and strong domestic and foreign competition in many markets. A primary cause of this highly competitive environment is the strength of our competitors. The industry consists of major domestic and international semiconductor companies, many of which have substantially greater financial, technical, marketing, distribution and other resources than we do. Cypress faces competition from other domestic and foreign high-performance integrated circuit manufacturers, many of which have advanced technological capabilities and have increased their participation in markets that are important to us. If we are unable to compete successfully in this environment, our business, operating results and financial condition will be seriously harmed.

Our ability to compete successfully in the rapidly evolving high performance portion of the semiconductor technology industry depends on many factors, including:


Our success in developing new products and manufacturing technologies;
The quality and price of our products;
The diversity of our product lines;
The cost effectiveness of our design, development, manufacturing and marketing efforts;
The pace at which customers incorporate our products into their systems; and
The number and nature of our competitors and general economic conditions.

Although we believe we currently compete effectively in the above areas to the extent they are within our control, given the pace of change in the industry, our current abilities are not a guarantee of future success.

We must build semiconductors based on our forecasts of demand, and if our forecasts are inaccurate, we may have large amounts of unsold products or we may not be able to fill all orders.

We order materials and build semiconductors based primarily on our internal forecasts, and secondarily on existing orders, which may be cancelled under many circumstances. Consequently, we depend on our forecasts to determine inventory levels for our products and the amount of manufacturing capacity that we need. Because our markets are volatile and subject to rapid technological and price changes, our forecasts may be wrong, and we may make too many or too few of certain products or have too much or too little manufacturing capacity. Also, our customers frequently place orders requesting product delivery almost immediately after the order is made, which makes forecasting customer demand all the more difficult. The above factors also make it difficult to forecast quarterly operating results. If we are unable to predict accurately the appropriate amount of product required to satisfy customer demand, our business, financial condition and results of operations could be seriously harmed.

We must spend heavily on equipment to stay competitive, and will be adversely impacted if we are unable to secure financing for such investments.

In order to remain competitive, semiconductor manufacturers generally must spend heavily on equipment to maintain or increase manufacturing capacity and capability. We have budgeted for approximately $380.0 million in expenditures on equipment in 2000 and anticipate significant continuing capital expenditures in subsequent years. In the past, we have reinvested a substantial portion of our cash flow from operations in capacity expansion and improvement programs. However, our cash flows from operations depend primarily on average selling prices, which generally decline over time, and on the per-unit cost of our products.

If we are unable to reduce the costs for our products at a rate at least as fast as the rate of decline in average selling prices for such products, we may not be able to generate enough cash flow from operations to maintain or increase manufacturing capability and capacity as necessary. In such a situation we would need to seek financing from external sources to satisfy our needs for manufacturing equipment and, if cash flow from operations declines too much, for operational cash needs as well. Such financing, however, may not be available on terms which are satisfactory to us or at all, in which case our business, financial condition and results of operations will be seriously harmed.




We compete with others to attract and retain key personnel, and any loss of, or inability to attract, such personnel would harm us.

To a greater degree than most non-technology companies, we depend on the efforts and abilities of certain key management and technical personnel. Our future success depends in part, upon our ability to retain such personnel, and to attract and retain other highly qualified personnel, particularly product and process engineers. We compete for these individuals with other companies, academic institutions, government institutions and other organizations. Competition for such personnel is intense, and we may not be successful in hiring or retaining new or existing qualified personnel. If we lose existing qualified personnel or are unable to hire new qualified personnel as needed, our business, financial condition and results of operations could be seriously harmed.

We face additional problems and uncertainties associated with international operations that could seriously harm us.

International sales represented approximately 50% of our revenues during the six months ended July 2, 2000 and 44% of our revenues during the same period in fiscal 1999. Our offshore assembly and test operations, as well as our international sales, face risks frequently associated with foreign operations, including:


currency exchange fluctuations,
political instability,
changes in local economic conditions,
the devaluation of local currencies,
import and export controls, and
changes in tax laws, tariffs and freight rates.

To the extent any such risks materialize, our business, financial condition and results of operations could be seriously harmed.

We are subject to many different environmental regulations, and compliance with them may be costly.

We are subject to many different governmental regulations related to the storage, use, discharge and disposal of toxic, volatile or otherwise hazardous chemicals used in its manufacturing process. Compliance with these regulations can be costly. In addition, over the last several years, the public has paid a great deal of attention to the potentially negative environmental impact of semiconductor manufacturing operations. This attention and other factors may lead to changes in environmental regulations that could force us to purchase additional equipment or comply with other potentially costly requirements. If we fail to control the use of, or to adequately restrict the discharge of, hazardous substances under present or future regulations, we could face substantial liability or suspension of our manufacturing operations, which could have a seriously harm our business, financial condition and results of operations.

We depend on third parties to transport our products and could be harmed if these parties experience problems.

We rely on independent carriers and freight forwarders to move our products between manufacturing plants and to our customers. We have limited control over these parties; however, any transport or delivery problems because of their errors, or because of unforeseen interruptions in their activities due to factors such as strikes, political instability, natural disasters and accidents, could seriously harm our business, financial conditions and results of operations and ultimately impact our relationship with our customers.

We may fail to integrate our business and technologies with those of companies we have recently acquired and that we may acquire in the future.

We completed four acquisitions in calendar year 1999, three acquisitions in the first six months 2000, recently announced a pending merger with Silicon Light Machines, and may pursue additional acquisitions in the future. If we fail to successfully or properly integrate these businesses, our quarterly and annual results may be seriously harmed. Integrating additional businesses, products and services could be expensive, time-consuming and a strain on our resources. Specific issues that we face with regard to prior and future acquisitions include:




the difficulty of integrating acquired technology or products;
the difficulty of assimilating the personnel of the acquired companies;
the difficulty of coordinating and integrating geographically dispersed operations;
our ability to retain customers of the acquired company;
the potential disruption of our on-going business and distraction of management;
the maintenance of brand recognition of acquired businesses;
the failure to successfully develop acquired in-process technology, resulting in the impairment of amounts currently capitalized as intangible assets; unanticipated expenses related to technology integration;
the maintenance of uniform standards, corporate cultures, controls, procedures and policies;
the impairment of relationships with employees and customers as a result of any integration of new management personnel; and
the potential unknown liabilities associated with acquired businesses.

We face a number of unknown risks associated with the year 2000 problem.

The year 2000 computer issue creates a variety of risks for us. The year 2000 computer problem refers to the potential for system and processing failures of date-related data as a result of computer-controlled systems using two digits rather than four to define the applicable year. For example, computer programs that have time-sensitive software may recognize a date represented as ”00“ as the year 1900 rather than the year 2000. This could result in a system failure or miscalculations causing disruptions of operations, including amount other things, interruptions in manufacturing, design and process development operations, disruptions in processing business transactions, and disruptions in other normal business activities. Issues related to the year 2000 computer problem could still arise. The risks involve:


potential warranty or other claims by customers with respect to errors in our products;
errors in systems we use to run our business;
errors in systems used by our suppliers;
errors in systems used by customers; and
potential reduced spending by customers as a result of concerns about potential year 2000 problems.

We have designed most of our products to be year 2000 compliant and have developed corrective measures for other products that were not originally designed to be year 2000 compliant. However, our products may be integrated into or used in conjunction with products supplied by other vendors. We cannot evaluate whether all of the products of other vendors are year 2000 compliant. We may face claims based on year 2000 problems in other companies’ products. We may in the future be required to defend our products in legal proceedings, which could be expensive regardless of the merits of these claims.

If our suppliers, vendors, partners, customers and service providers fail to correct their year 2000 problems, these failures could result in an interruption in, or a failure of, our normal business activities or operations. If a year 2000 problem occurs, it may be difficult to determine which party’s products have caused the problem. These failures could interrupt our operations and damage our relationships with customers. Due to the general uncertainty inherent in the year 2000 problem resulting from the readiness of third-party suppliers and vendors, we are unable to determine at this time whether third-party year 2000 failures could harm our business, results of operations and financial condition.




Item 3—Quantitative and Qualitative Disclosure About Market Risk

Cypress is exposed to financial market risks, including changes in interest rates and foreign currency exchange rates. To mitigate these risks, Cypress utilizes derivative financial instruments. Cypress does not use derivative financial instruments for speculative or trading purposes.

The fair value of Cypress’s investment portfolio or related income would not be significantly impacted by either a 100 basis point increase or decrease in interest rates due mainly to the short-term nature of the major portion of Cypress’s investment portfolio. An increase in interest rates would not significantly increase interest expense due to the fixed nature of Cypress’s debt obligations.

A majority of Cypress’s revenue and capital spending is transacted in U.S. dollars. However, Cypress does enter into transactions in other currencies, primarily Japanese yen and certain other European currencies. To protect against reductions in value and the volatility of future cash flows caused by changes in foreign exchange rates, Cypress has established revenue and balance sheet hedging programs. Cypress’s hedging programs reduce, but do not always eliminate, the impact of foreign currency rate movements. There have been no significant changes in the market risk disclosures during the three months ended July 2, 2000 as compared to the discussion in our 1999 Annual Report on Form 10-K for the year ended January 2, 2000.




PART II.   OTHER INFORMATION

Item 1 — Legal Proceedings

The information required by this item is included in Part I in Note 14 of Notes to the Condensed Consolidated Financial Statements.

Item 4 —Submission of Matters to a vote of Security Holders

     On May 4, 2000, at Cypress’s Annual Meeting of Shareholders, the nominated slate of directors was elected, the appointment of PricewaterhouseCoopers as Cypress’s independent accountants was ratified, Cypress’s proposal to increase the number of authorized shares of common stock was approved, and the existing policy for the indemnification of officers, directors, employees and agents was clarified. The results of the votes were as follows:

(1)  Election of Directors:


Total Votes For
Each Director

Total Votes
Withheld From
Each Director

     T.J. Rodgers   98,778,474   649,941  
   Fred B. Bialek  97,794,369   1,634,046  
   Eric A. Benhamou  98,741,624   686,791  
   John C. Lewis  98,764,525   663,890  
   Alan F. Shugart  98,727,311   701,104  

(2)   Ratify the appointment of PricewaterhouseCoopers as the Independent Accountants of Cypress for the fiscal year ending December 31, 2000:


    For   99,228,003   Against   130,721   Abstain   70,291  

(3)   To approve the amendment to our Restated Certificate of Incorporation to increase the number of authorized shares of our common stock and to clarify our existing policy for the indemnification of our officers, directors, employees and agents.


    For   78,703,402   Against   20,611,501  
   Abstain  114,112   Broker Non-Vote  113,512  



Item 6 — Exhibits and Reports on Form 8-K

a. Exhibits

Exhibit 27.1—Financial Data Schedule.

b. Reports on Form 8-K

On June 14, 2000, Cypress filed a report on Form 8-K, which reported under Item 5, that on May 24, 2000, we completed a merger with Alation Systems, Inc. which was accounted for as a pooling of interests. Pursuant to Item 7, we attached the Consolidated Financial Statements reflecting the merger with Alation.

On June 16, 2000, we filed a report on Form 8-K/A, which reported under Item 7 corrections to the report of independent accountants and Exhibit 23.1.

On June 21, 2000, we filed a report on Form 8-K, which reported under Item 7 Exhibits 12.1 and 99.1 related to our 3.75% Convertible Subordinated Notes due in 2005.




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


    CYPRESS SEMICONDUCTOR CORORATION


By: /s/ T.J. RODGERS
——————————————
T.J. Rodgers
President and Chief Executive Officer

     


By: /s/ EMMANUEL HERNANDEZ
——————————————
Emmanuel Hernandez
Vice President, Finance and Administration and
Chief Financial Officer

Dated: August 16, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission